Interstitial fluid pressure predicts survival in patients with cervix cancer independent of clinical prognostic factors and tumor oxygen measurements.

The purpose of this study was to determine the independent prognostic significanceof interstitial fluid pressure (IFP) measurements in cervix cancer. A total of 102 patients with newly diagnosed cervix cancer were accrued to this prospective study. There were 31 International Federation of Gynecology and Obstetrics stage IB or IIA tumors, 40 IIB tumors, and 31 IIIB tumors. The median size was 5 cm (range, 2-10 cm). Pelvic lymphadenopathy was identified radiographically in 20 patients. IFP was measured at examination under anesthesia using a wick-in-needle technique. Multiple measurements were made in each tumor. The mean IFP in individual tumors ranged from -3 to 48 mm Hg, and the median for the entire cohort was 19 mm Hg. Treatment consisted of external beam and intracavitary radiation without chemotherapy. Median follow-up was 2.5 years. The 3-year disease-free survival of all of the patients was 53%. Disease-free survival was 34% in patients with IFP >19 mm Hg, and 68% in those with lower IFP (P = 0.002). To evaluate rigorously the independent prognostic significance of IFP measurements relative to established clinical factors, a multivariate model was first developed using stepwise selection of clinical covariates. Tumor size (P = 0.0003) and pelvic lymph node status (P = 0.0016) comprised the clinical model. IFP, when added to this model, provided additional independent prognostic information (P = 0.0013). IFP was also significant (P = 0.0027) when the clinical factors and hypoxic proportion as determined with the Eppendorf electrode were analyzed together. Patients with high IFP were more likely to recur both locally and at distant sites. This study is the first to document a strong, independent prognostic importance of pretreatment IFP measurements in cervix cancer. Patients with high IFP are significantly more likely than those with low IFP to recur after radiotherapy and die of progressive disease, independent of clinical prognostic factors and the results of tumor oxygen measurements.

[1]  B. I. Choi,et al.  Uterine cervical carcinoma: evaluation of pelvic lymph node metastasis with MR imaging. , 1994, Radiology.

[2]  R K Jain,et al.  Geometric Resistance and Microvascular Network Architecture of Human Colorectal Carcinoma , 1997, Microcirculation.

[3]  A. Fyles,et al.  Oxygenation predicts radiation response and survival in patients with cervix cancer. , 1998, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[4]  A. Fyles,et al.  Heterogeneity of polarographic oxygen tension measurements in cervix cancer: an evaluation of within and between tumor variability, probe position, and track depth. , 1997, International journal of radiation oncology, biology, physics.

[5]  R K Jain,et al.  Geometric resistance to blood flow in solid tumors perfused ex vivo: effects of tumor size and perfusion pressure. , 1989, Cancer research.

[6]  R K Jain,et al.  Interstitial hypertension in carcinoma of uterine cervix in patients: possible correlation with tumor oxygenation and radiation response. , 1991, Cancer research.

[7]  R K Jain,et al.  Taxane-induced apoptosis decompresses blood vessels and lowers interstitial fluid pressure in solid tumors: clinical implications. , 1999, Cancer research.

[8]  J F Gross,et al.  Analysis of the effects of oxygen supply and demand on hypoxic fraction in tumors. , 1995, Acta oncologica.

[9]  R K Jain,et al.  Pharmacologic modification of tumor blood flow and interstitial fluid pressure in a human tumor xenograft: network analysis and mechanistic interpretation. , 1995, Microvascular research.

[10]  P. Carmeliet,et al.  Angiogenesis in cancer and other diseases , 2000, Nature.

[11]  R. Jain,et al.  Effect of radiation on interstitial fluid pressure and oxygenation in a human tumor xenograft. , 1996, Cancer research.

[12]  R. Gray.  A Class of $K$-Sample Tests for Comparing the Cumulative Incidence of a Competing Risk , 1988 .

[13]  L. H. Gray,et al.  The Histological Structure of Some Human Lung Cancers and the Possible Implications for Radiotherapy , 1955, British Journal of Cancer.

[14]  R K Jain,et al.  Transport of fluid and macromolecules in tumors. I. Role of interstitial pressure and convection. , 1989, Microvascular research.

[15]  E. Rofstad,et al.  Interstitial fluid pressure and capillary diameter distribution in human melanoma xenografts. , 1999, Microvascular research.

[16]  M. Hashida,et al.  Experimental study on lymphatic vascular changes in the development of cancer. , 1981, Lymphology.

[17]  M Lunn,et al.  Applying Cox regression to competing risks. , 1995, Biometrics.

[18]  R K Jain,et al.  Transport of fluid and macromolecules in tumors. III. Role of binding and metabolism. , 1991 .

[19]  D. Longo,et al.  Interstitial pressure of subcutaneous nodules in melanoma and lymphoma patients: changes during treatment. , 1993, Cancer research.

[20]  V. Bertone,et al.  Omega-3 fatty acids can improve radioresponse modifying tumor interstitial pressure, blood rheology and membrane peroxidability. , 1994, Anticancer research.

[21]  R K Jain,et al.  Interstitial hypertension in superficial metastatic melanomas in humans. , 1991, Cancer research.

[22]  C E LUMSDEN,et al.  The significance of the tissue pressure of normal testicular and of neoplastic (Brown-Pearce carcinoma) tissue in the rabbit. , 1950, The Journal of pathology and bacteriology.

[23]  R K Jain,et al.  Determinants of tumor blood flow: a review. , 1988, Cancer research.

[24]  R. Jain,et al.  Viscous resistance to blood flow in solid tumors: effect of hematocrit on intratumor blood viscosity. , 1989, Cancer research.

[25]  M. Dewhirst,et al.  Concepts of oxygen transport at the microcirculatory level. , 1998, Seminars in radiation oncology.

[26]  R K Jain,et al.  Effect of transvascular fluid exchange on pressure-flow relationship in tumors: a proposed mechanism for tumor blood flow heterogeneity. , 1996, Microvascular research.

[27]  S. Chagnon,et al.  Pelvic cancers: staging of 139 cases with lymphography and fine-needle aspiration biopsy. , 1989, Radiology.

[28]  R. Jain,et al.  Lack of general correlation between interstitial fluid pressure and oxygen partial pressure in solid tumors. , 1995, Microvascular research.

[29]  A C Guyton,et al.  Interstitial Fluid Pressure , 1968, Circulation research.

[30]  R. Jain,et al.  Transmural coupling of fluid flow in microcirculatory network and interstitium in tumors. , 1997, Microvascular research.

[31]  R. Jain,et al.  Dexamethasone reduces the interstitial fluid pressure in a human colon adenocarcinoma xenograft. , 1993, Cancer research.

[32]  H. Lyng,et al.  Interstitial fluid pressure, perfusion rate and oxygen tension in human melanoma xenografts. , 1996, The British journal of cancer. Supplement.

[33]  M Ancukiewicz,et al.  Anti-Vascular endothelial growth factor treatment augments tumor radiation response under normoxic or hypoxic conditions. , 2000, Cancer research.

[34]  R K Jain,et al.  Interstitial hypertension in human breast and colorectal tumors. , 1992, Cancer research.

[35]  T. Eagleton,et al.  The Significance Of Theory , 1990 .

[36]  A. Fyles,et al.  The relationship between elevated interstitial fluid pressure and blood flow in tumors: a bioengineering analysis. , 1999, International journal of radiation oncology, biology, physics.

[37]  R. Jain,et al.  Absence of functional lymphatics within a murine sarcoma: a molecular and functional evaluation. , 2000, Cancer research.

[38]  A. Fyles,et al.  Interstitial fluid pressure in cervical carcinoma , 1998, Cancer.

[39]  R K Jain,et al.  Microvascular pressure is the principal driving force for interstitial hypertension in solid tumors: implications for vascular collapse. , 1992, Cancer research.

[40]  Paolo A. Netti,et al.  Solid stress inhibits the growth of multicellular tumor spheroids , 1997, Nature Biotechnology.

[41]  R. Weichselbaum,et al.  Blockade of the Vascular Endothelial Growth Factor Stress Response Increases the Antitumor Effects of Ionizing Radiation , 1999 .

[42]  K Messmer,et al.  Interstitial hypertension in head and neck tumors in patients: correlation with tumor size. , 1992, Cancer research.